CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 49 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,072,836 | +68.7% | 177,317 | +94.0% | 0.00% | – |
Q2 2023 | $1,228,497 | -27.7% | 91,406 | -10.8% | 0.00% | -100.0% |
Q1 2023 | $1,698,919 | +111.0% | 102,468 | +136.7% | 0.00% | – |
Q4 2022 | $805,324 | +376.5% | 43,297 | +228.8% | 0.00% | – |
Q3 2022 | $169,000 | 0.0% | 13,170 | -45.5% | 0.00% | – |
Q2 2022 | $169,000 | -80.2% | 24,145 | -76.5% | 0.00% | – |
Q1 2022 | $852,000 | +616.0% | 102,770 | +482.8% | 0.00% | – |
Q4 2021 | $119,000 | -38.7% | 17,633 | -51.9% | 0.00% | – |
Q3 2021 | $194,000 | -62.1% | 36,624 | -58.9% | 0.00% | – |
Q2 2021 | $512,000 | +369.7% | 89,012 | +172.6% | 0.00% | – |
Q4 2020 | $109,000 | -77.7% | 32,654 | -80.2% | 0.00% | – |
Q3 2020 | $489,000 | +652.3% | 164,702 | +1079.7% | 0.00% | – |
Q2 2020 | $65,000 | -50.8% | 13,961 | -43.7% | 0.00% | – |
Q3 2019 | $132,000 | +80.8% | 24,776 | +32.4% | 0.00% | – |
Q4 2017 | $73,000 | +21.7% | 18,720 | -22.0% | 0.00% | – |
Q3 2017 | $60,000 | +27.7% | 23,999 | -63.4% | 0.00% | – |
Q2 2016 | $47,000 | -69.3% | 65,594 | +42.5% | 0.00% | -100.0% |
Q3 2014 | $153,000 | – | 46,039 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
XML Financial, LLC | 40,000 | $119,000 | 0.04% |